PharmaCyte Biotech, Inc. (PMCB)
NASDAQ
0.4508
-0.0089 (-1.94%)
Closed
Sep 21, 2026
Day's Range
0.44010.4600
52 wk Range
0.33391.51
Financial Statements - PMCB - PharmaCyte Biotech, Inc.
Revenue
0
Net Income
-19.42M▼ 163.4%
EBITDA
8.09M▲ 121.3%
Free Cash Flow
-5.15M▼ 73.0%
Income Statement
| Period Ending | 2026-04-30 | 2025-04-30 | 2024-04-30 | 2023-04-30 | 2022-04-30 | 2021-04-30 |
|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Goods | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -5.30M | -4.37M | -6.52M | -6.45M | -4.39M | -3.62M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | -14.85M | 33.61M | 3.45M | 202K | -4.28K | 74.79K |
| Pre Tax Income | -19.42M | 30.65M | 333.76K | -4.31M | -4.23M | -3.55M |
| Income Tax | 0 | - | - | - | - | - |
| Net Income | -19.42M | 30.65M | 333.76K | -4.31M | -4.23M | -3.55M |
| EPS Basic | - | 3.19 | -1.8 | -0.22 | -0.27 | -2.45 |
| EPS Diluted | - | 3.19 | -1.8 | -0.22 | -0.27 | -2.45 |
| Basic Shares Outstanding | - | 7.32M | 9.58M | 19.48M | 15.52M | 1.44M |
| Diluted Shares Outstanding | - | 7.32M | 9.58M | 19.48M | 15.52M | 1.44M |
| Ebit | -5.30M | -4.37M | -6.52M | -6.45M | -4.23M | -3.54M |
| Ebitda | 8.09M | -37.99M | -6.44M | -6.45M | -4.23M | -3.62M |
| Net Income Continuous Operations | -19.42M | 30.65M | 333.76K | -4.31M | -4.23M | -3.55M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | 3.50M | 6.16M | 15.05M | 0 | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
